The emerging picture is that breast and ovarian cancer risks in BRCA1 and BRCA2 carriers are substantially higher than in the general population, but that they are considerably affected by nongenetic, environmental factors, and by additional genetic modifiers. Here, BRCA1 is linked to ovarian cancer.